PT  - JOURNAL ARTICLE
AU  - Piha-Paul, Sarina A
AU  - Geva, Ravit
AU  - Tan, Tira J
AU  - Lim, Darren WT
AU  - Hierro, Cinta
AU  - Doi, Toshikiko
AU  - Rahma, Osama
AU  - Lesokhin, Alexander
AU  - Luke, Jason John
AU  - Otero, Javier
AU  - Nardi, Lisa
AU  - Singh, Angad
AU  - Xyrafas, Alexandros
AU  - Chen, Xinhui
AU  - Mataraza, Jennifer
AU  - Bedard, Philippe L
TI  - First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas
AID  - 10.1136/jitc-2021-002863
DP  - 2021 Aug 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e002863
VI  - 9
IP  - 8
4099  - http://jitc.bmj.com/content/9/8/e002863.short
4100  - http://jitc.bmj.com/content/9/8/e002863.full
SO  - J Immunother Cancer2021 Aug 01; 9
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.